全文获取类型
收费全文 | 7547篇 |
免费 | 462篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 136篇 |
儿科学 | 117篇 |
妇产科学 | 63篇 |
基础医学 | 343篇 |
口腔科学 | 172篇 |
临床医学 | 971篇 |
内科学 | 651篇 |
皮肤病学 | 84篇 |
神经病学 | 411篇 |
特种医学 | 115篇 |
外国民族医学 | 1篇 |
外科学 | 603篇 |
综合类 | 1117篇 |
预防医学 | 2021篇 |
眼科学 | 47篇 |
药学 | 746篇 |
29篇 | |
中国医学 | 301篇 |
肿瘤学 | 139篇 |
出版年
2023年 | 165篇 |
2022年 | 213篇 |
2021年 | 368篇 |
2020年 | 419篇 |
2019年 | 349篇 |
2018年 | 313篇 |
2017年 | 328篇 |
2016年 | 248篇 |
2015年 | 285篇 |
2014年 | 640篇 |
2013年 | 699篇 |
2012年 | 590篇 |
2011年 | 555篇 |
2010年 | 441篇 |
2009年 | 369篇 |
2008年 | 312篇 |
2007年 | 307篇 |
2006年 | 257篇 |
2005年 | 202篇 |
2004年 | 155篇 |
2003年 | 135篇 |
2002年 | 87篇 |
2001年 | 90篇 |
2000年 | 66篇 |
1999年 | 60篇 |
1998年 | 34篇 |
1997年 | 27篇 |
1996年 | 46篇 |
1995年 | 42篇 |
1994年 | 25篇 |
1993年 | 23篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 14篇 |
1989年 | 15篇 |
1988年 | 19篇 |
1987年 | 10篇 |
1986年 | 5篇 |
1985年 | 17篇 |
1984年 | 21篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1981年 | 9篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1973年 | 4篇 |
排序方式: 共有8067条查询结果,搜索用时 203 毫秒
41.
《The Foot》2022
ObjectivesCompare the functional outcomes of comparative studies of ankle arthrodesis (AA) and total ankle replacements (TAR).DesignSystematic review using PRISMA guidelines.Data SourcesMedline, Cochrane and EMBASE databases in July 2020.Eligibility CriteriaStudies that directly compared TAR and AA which reported patient reported outcomes measures (PROMs) of pain, function and quality of life.Data Extraction and SynthesisTwo authors independently reviewed all papers. PROMs were allocated into pain, function or quality of life domains. Two summary statistics were created to allow for analysis of the PROMs. These statistics were the mean difference in post-operative score and the mean difference in the change of score.Results1323 papers were assessed of which 20 papers were included. 898 ankle arthrodesis and 1638 ankle replacements were evaluated. The mean follow up was 3.3 years (range 0.5–13.0 years). AA patients had a mean age of 55.7 (range 20–82) and TAR 62.5 (range 21–89).There was major heterogeneity in outcomes used. We were unable to find a significant difference between the reported change in PROMs following TAR and AA. 29.3% of PROMs and their subscores showed TAR had better outcomes, 68.7% showed no significant difference and only 2.0% showed AA to have better outcomes.ConclusionsThe majority of published studies found equality in patient reported outcomes following TAR and AA although the quality of the studies was of low-level evidence. There is an urgent need for randomised controlled studies to definitively answer this important clinical question. 相似文献
42.
43.
《Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society》2020,28(12):1525-1538
44.
45.
目的:探讨血液标本采集中存在的护理缺陷的原因并提出有效的改进措施。方法回顾性分析该站2016年1一5月的33215例血液标本,分析血液标本采集中57例存在护理缺陷的原因,结合原因提出有效的改进方法。结果对该次33215例血液标本进行分析,在57例有护理缺陷的血液标本中信息不准确或不完整30例(52.6%)是该次采血护理缺陷的主要原因,标本质量缺陷15例(26.3%)是该次采血护理缺陷的次要原因。结论强化采血护士对标准操作规程及实践培训是改进血液标本采集护理的重要措施,优化调整排班,建立缺陷标本沟通和反馈途径,并持续改进,是保证标本质量,降低缺陷发生率的重要途径。 相似文献
46.
It is estimated that 20 million children are exposed to tuberculosis (TB) each year, making TB a global paediatric health emergency. TB preventative efforts have long been overlooked. With the view of achieving “TB elimination” in “our lifetime”, this paper explores challenges and potential solutions in the TB prevention cascade, including identifying children who have been exposed to TB; detecting TB infection in these children; identifying those at highest risk of progressing to disease; implementing treatment of TB infection; and mobilizing multiple stakeholders support to successfully prevent TB. 相似文献
47.
48.
心力衰竭(心衰)是各种心脏疾病的严重和终末阶段,已经成为影响我国居民健康的重要公共卫生问题。针对目前我国心衰规范化诊治方面存在的问题,积极开展心衰医疗质量评价和改进,提高心衰诊治的规范性,具有重要的意义。自从2018年3月成立国家心血管病中心心力衰竭专病医联体(HFMU-NCCD),加入医院已超过1000家。国家心血管病医疗质量控制中心专家委员会心力衰竭专家工作组(NCCQI-HF)纳入2017~2020年期间在医联体单位住院的心衰患者,开展全国心衰医疗质量评价,包括心衰的诊断与评估、指南指导的药物治疗及器械治疗、临床结局等,并依据该研究结果和我们的思考,撰写成本报告。此外,通过与China-HF注册研究(2012~2015年)结果及美国心脏学会(AHA)的“跟着指南走——心力衰竭(GWTG-HF)”项目结果做比较,发现当前我国在心衰诊疗规范化方面较以前有明显改善,但仍存在诊疗不足、治疗不当及治疗过度等现象,不同等级医院之间也存在差异,而且与美国比较仍有一定差距,也体现出心衰患者特点以及国情的不同。未来需要提高数据填报数量和质量,持续开展医疗质量控制和改进,以便从整体上提高我国心衰的诊治水平。 相似文献
49.
Zev M. Nakamura Allison M. Deal Kirsten A. Nyrop Yi Tang Chen Laura J. Quillen Tucker Brenizer Hyman B. Muss 《The oncologist》2021,26(2):147-156
Background
Depression and anxiety are common in patients with breast cancer and associated with worse quality of life and treatment outcomes. Yet, these symptoms are often underrecognized and undermanaged in oncology practice. The objective of this study was to describe depression and anxiety severity and associated patient factors during adjuvant or neoadjuvant chemotherapy in women with early breast cancer using repeated single-item reports.Materials and Methods
Depression and anxiety were measured from consecutive patients and their clinicians during chemotherapy infusion visits. Associations between psychiatric symptoms and patient characteristics were assessed using Fisher's exact tests for categorical variables and t tests for continuous variables. The joint relationship of covariates significant in unadjusted analyses was evaluated using log-binomial regression. Cohen's kappa was used to assess agreement between patient- and clinician-reported symptoms.Results
In a sample of 256 patients, 26% reported at least moderately severe depression, and 41% reported at least moderately severe anxiety during chemotherapy, representing a near doubling in the prevalence of these symptoms compared with before chemotherapy. Patient-provider agreement was fair (depression: κ = 0.31; anxiety: κ = 0.28). More severe psychiatric symptoms were associated with being unmarried, having worse function, endorsing social activity limitations, using psychotropic medications, and having a mental health provider. In multivariable analysis, social activity limitations were associated with more severe depression (relative risk [RR], 2.17; 95% confidence interval [CI], 1.36–3.45) and anxiety (RR, 1.48; 95% CI, 1.05–2.09).Conclusion
Oncologists frequently underestimate patients’ depression and anxiety and should consider incorporating patient-reported outcomes to enhance monitoring of mental health symptoms.Implications for Practice
In this sample of 256 patients with breast cancer, depression and anxiety, measured using single-item toxicity reports completed by patients and providers, were very common during adjuvant or neoadjuvant chemotherapy. Patient-reported depression and anxiety of at least moderate severity were associated with multiple objective indicators of psychiatric need. Unfortunately, providers underrecognized the severity of their patients’ mental health symptoms. The use of patient-reported, single-item toxicity reports can be incorporated into routine oncology practice and provide clinically meaningful information regarding patients’ psychological health.50.